champc/iStock via Getty Images Tech stocks’ recent selloff has created a buying opportunity despite elevated market volatility and geopolitical uncertainty, Steve Cress said on Seeking Alpha ’s Investing Experts podcast. Cress said investor sentiment has been dominated by fear, driving rotations into cash and traditional safe havens and leading to indiscriminate selling, even among companies with ...
champc/iStock via Getty Images Tech stocks’ recent selloff has created a buying opportunity despite elevated market volatility and geopolitical uncertainty, Steve Cress said on Seeking Alpha ’s Investing Experts podcast. Cress said investor sentiment has been dominated by fear, driving rotations into cash and traditional safe havens and leading to indiscriminate selling, even among companies with strong fundamentals. He added that such periods of uncertainty typically represent the worst phase for markets, as investors react to unknown outcomes rather than underlying data. Cress said the pullback has been particularly pronounced in technology stocks, which have sold off sharply since late last year despite continued strength in earnings and growth expectations. He highlighted Micron Technology ( MU ) , Lumentum ( LITE ) , and Credo Technology ( CRDO ) as examples of AI-linked names that have declined significantly from recent highs but continue to exhibit strong earnings growth. He noted that Micron, in particular, offers a combination of high-growth and low valuation, with forward earnings growth far exceeding sector averages while trading at a relatively low multiple. More broadly, Cress said market corrections driven by sentiment rather than fundamentals tend to present attractive entry points, particularly when high-quality stocks are sold off alongside weaker names. He added that historical data shows investors who buy during periods of market stress are often rewarded with strong returns over time, especially when focusing on companies with solid growth, profitability, and valuation metrics. Cress said he favors a disciplined, data-driven approach, encouraging investors to focus on fundamentals rather than short-term market movements and to accumulate positions during periods of panic selling. He added that while uncertainty remains elevated, some technology stocks have already begun to stabilize and rebound, suggesting the broader market correction may be nea...
Joaquin Corbalan/iStock via Getty Images USA Rare Earth ( USAR ) down 3.8% pre-market Monday after saying it agreed to acquire Brazilian rare earths miner Serra Verde Group for $300M in cash and 126.85M common shares, implying an equity value of ~$2.8B. USA Rare Earth ( USAR ) said the Serra Verde project in Brazil secures one of the industry's most strategic operations as the only scaled producer...
Joaquin Corbalan/iStock via Getty Images USA Rare Earth ( USAR ) down 3.8% pre-market Monday after saying it agreed to acquire Brazilian rare earths miner Serra Verde Group for $300M in cash and 126.85M common shares, implying an equity value of ~$2.8B. USA Rare Earth ( USAR ) said the Serra Verde project in Brazil secures one of the industry's most strategic operations as the only scaled producer of all four magnetic rare earth elements—neodymium, praseodymium, dysprosium, and terbium—outside Asia, along with a 15-year 100% offtake agreement with a special purpose vehicle capitalized by various U.S. government parties. The operation, which is fully permitted and entered production in 2024 following more than $1.1B in capital investment, is projected to produce 6,400 metric tons/year of oxide and achieve an annualized run-rate EBITDA of $550M-$650M by the end of 2027. Sierra Verde Chairman Mick Davis and CEO Thras Moraitis will be added to USA Rare Earth's (UAR) board, and Moraitis will become President of the combined company. More on USA Rare Earth USA Rare Earth Shareholder/Analyst Call Transcript USA Rare Earth: Buying The Pullback Ahead Of Key Catalysts USA Rare Earth: Take Advantage Of Momentum Swings
Chutz99/iStock via Getty Images Summary I reiterated a hold rating to Fastenal Company ( FAST ) earlier this year because of concerns surrounding weak pricing and slowing FMI deployment. For this update, I still think a hold rating makes sense. Demand looks better, with strong and broad-based growth across categories and geographies, and the P&L still showed operating leverage. The problem is that...
Chutz99/iStock via Getty Images Summary I reiterated a hold rating to Fastenal Company ( FAST ) earlier this year because of concerns surrounding weak pricing and slowing FMI deployment. For this update, I still think a hold rating makes sense. Demand looks better, with strong and broad-based growth across categories and geographies, and the P&L still showed operating leverage. The problem is that pricing has weakened further, and the latest Section 232 tariff changes could make margin pressure persist for longer than expected. The valuation is also still not at a cheap enough level to justify a buy yet. Earnings results update FAST reported 1Q26 results last week. Total revenue grew 12.4% y/y to $2.2 billion, with growth being broad-based across fasteners, safety, and other industrial products. Margins were rather weaker this quarter. Gross margin was down 47 bps y/y to 44.6%, mainly due to unfavorable price/cost, transportation headwinds, and certain customer rebates. FAST did see some operating leverage as SG&A came down 70 bps y/y to 24.3% of revenue. In terms of absolute profit dollars, EBIT was up 13.6% y/y to $447.6 million, with EBIT margin up 23 bps to 20.3%. This led to net income growth of 13.8% y/y to $340 million, and EPS growing to $0.30 from $0.26 in Q1 2025. Altogether, this was not a bad quarter in absolute terms. Revenue growth was good, category growth was broad, and profits still grew at a double-digit rate. The problem is that the margin side has turned weak. What got better With more than just one good month of performance (January previously), a solid revenue growth performance this quarter, and March still going strong, the obvious positive takeaway here is that the demand picture looks much better now than it did in January. Specifically, March average daily sales were up 11.5% y/y, and growth was broad-based, with Fastener sales up 14.4% y/y, Safety was up 11.3%, and other industrial products grew 11%. Every reported geography's growth was ...
India’s central bank eased some restrictions on banks’ offshore currency market transactions that it had imposed earlier this month to shore up the rupee. The Reserve Bank of India said on Monday that it would withdraw measures issued April 1 that barred lenders from offering rupee-linked non-deliverable forwards, the most widely used tools for offshore trading. However, banks still can’t carry ou...
India’s central bank eased some restrictions on banks’ offshore currency market transactions that it had imposed earlier this month to shore up the rupee. The Reserve Bank of India said on Monday that it would withdraw measures issued April 1 that barred lenders from offering rupee-linked non-deliverable forwards, the most widely used tools for offshore trading. However, banks still can’t carry out all foreign-exchange derivative deals with so-called related parties, the RBI said. Transactions that are permitted include cancellation and rollover of existing deals and those under the so-called ‘back-to-back’ route. Read More: RBI Governor Says Forex Market Curbs Won’t Remain Forever (3) The steps helped stabilize the rupee after it weakened past 95 per dollar to a record low late March amid the oil shock sparked by the Iran war. The currency has recovered more than 2% after the first set of measures were announced on March 27.
Taiwan Semiconductor Manufacturing (NYSE:TSM) makes the chips inside nearly every advanced device on earth, from iPhones to AI accelerators. Its dominance is so complete that even competitors depend on it. YieldMax TSM Option Income Strategy ETF (NYSE:TSMY) offers a way to collect weekly income from this critical company without owning it outright. How the covered ... TSM gained 147% last year; TS...
Taiwan Semiconductor Manufacturing (NYSE:TSM) makes the chips inside nearly every advanced device on earth, from iPhones to AI accelerators. Its dominance is so complete that even competitors depend on it. YieldMax TSM Option Income Strategy ETF (NYSE:TSMY) offers a way to collect weekly income from this critical company without owning it outright. How the covered ... TSM gained 147% last year; TSMY investors missed 38 points
Honeywell International ( HON ) is reportedly nearing a deal to divest its productivity solutions and services business to industrial manufacturer Brady Corp ( BRC ). Brady is in talks to pay $1.4B in cash for the asset. The companies are hammering out details of a transaction that might be announced as early as Monday, people familiar with the matter told Bloomberg . Brady Corp ( BRC ) stock tick...
Honeywell International ( HON ) is reportedly nearing a deal to divest its productivity solutions and services business to industrial manufacturer Brady Corp ( BRC ). Brady is in talks to pay $1.4B in cash for the asset. The companies are hammering out details of a transaction that might be announced as early as Monday, people familiar with the matter told Bloomberg . Brady Corp ( BRC ) stock ticked 3.3% lower in premarket trading. More on Honeywell International, Brady Honeywell: The Premier Value Play In Industrials At A Discount Honeywell International Inc. (HON) Presents at JPMorgan Industrials Conference 2026 Transcript Honeywell International Inc. (HON) Presents at Bank of America Global Industrials Conference 2026 Transcript Tariff shock ripples through industrials as BRP pulls outlook Snapshot of Quant and Wall St. ratings for quantum computing stocks after Nvidia's latest push
AI-driven software company outlines its idiosnycratic beliefs, arguing for greater social tolerance and understanding while looking ahead to future warfare as a grim inevitabilty
AI-driven software company outlines its idiosnycratic beliefs, arguing for greater social tolerance and understanding while looking ahead to future warfare as a grim inevitabilty
The Pure Electric Truck Chassis Market is witnessing substantial growth, expected to reach USD 17.98 billion by 2032 with a CAGR of 11.36%. This growth is driven by advances in technology integration within electric truck chassis, including battery integration, e-axles, and software-defined controls that enhance performance and reduce total ownership costs. The development of "skateboard" and semi...
The Pure Electric Truck Chassis Market is witnessing substantial growth, expected to reach USD 17.98 billion by 2032 with a CAGR of 11.36%. This growth is driven by advances in technology integration within electric truck chassis, including battery integration, e-axles, and software-defined controls that enhance performance and reduce total ownership costs. The development of "skateboard" and semi-integrated chassis designs, along with modular platforms, allows for improved stability,...
Prelude Therapeutics ( PRLD ) has priced a public offering of more than 18M shares of its voting common stock at $4.44 each, along with pre-funded warrants for up to 2.25M additional shares at $4.4399 each. Gross proceeds are estimated to be approximately $90M. The offering is expected to close on or about April 21, 2026, subject to the satisfaction of customary closing conditions. The company int...
Prelude Therapeutics ( PRLD ) has priced a public offering of more than 18M shares of its voting common stock at $4.44 each, along with pre-funded warrants for up to 2.25M additional shares at $4.4399 each. Gross proceeds are estimated to be approximately $90M. The offering is expected to close on or about April 21, 2026, subject to the satisfaction of customary closing conditions. The company intends to use the net proceeds from the offering primarily for general corporate purposes, which may include funding research, preclinical and clinical development of its product candidates, increasing its working capital, and capital expenditures. The offering was led by new investor RA Capital Management with participation from Soleus Capital, as well as other new and existing healthcare dedicated investors. Goldman Sachs & Co. LLC, Evercore ISI and Citizens Capital Markets are acting as the joint book-running managers for the offering. PRLD shares +10.36% premarket. Source: Press Release More on Prelude Therapeutics Prelude climbs as FDA clears study for Incyte-partnered cancer candidate Seeking Alpha’s Quant Rating on Prelude Therapeutics Historical earnings data for Prelude Therapeutics Financial information for Prelude Therapeutics
(RTTNews) - USA Rare Earth Inc. (USAR) on Monday said it has agreed to acquire Serra Verde Group, owner of the Pela Ema rare earth mine and processing plant in Brazil, in a deal valued at about $2.8 billion.
(RTTNews) - USA Rare Earth Inc. (USAR) on Monday said it has agreed to acquire Serra Verde Group, owner of the Pela Ema rare earth mine and processing plant in Brazil, in a deal valued at about $2.8 billion.
Mohamad Faizal Bin Ramli/iStock via Getty Images Last summer, I believed that AMETEK, Inc. ( AME ) was continuing with M&A to complement modest organic growth. The high-quality and niche industrial player announced the acquisition of FARO Technologies, which is a much larger and somewhat unusual deal for Ametek. Ever since, shares have risen by a third, vastly outperforming the wider market, as a ...
Mohamad Faizal Bin Ramli/iStock via Getty Images Last summer, I believed that AMETEK, Inc. ( AME ) was continuing with M&A to complement modest organic growth. The high-quality and niche industrial player announced the acquisition of FARO Technologies, which is a much larger and somewhat unusual deal for Ametek. Ever since, shares have risen by a third, vastly outperforming the wider market, as a premium player is awarded more premium valuations here. Trading at a 30 times earnings multiple, or 3% and change earnings yield, does not compete with risk-free rates. However, the long-term track record of compounded earnings growth is what counts, making shares not necessarily overextended, although valued at too much of a premium to see imminent appeal. Other interesting IPOs are discussed more extensively at Value In Corporate Events . Powering On Recently, investors in Ametek have seen quite some good news. In February, Ametek announced a 10% increase in the quarterly dividend, now paid at $0.34 per share, for an annual payout of $1.36 per share. This hike followed the announcement of a bolt-on deal of LKC in February, used for effective diagnosis and management of ophthalmic conditions, yet unfortunately, no financial details have been announced. Reported sales rose by nearly 7% to $7.40 billion, as fourth-quarter sales rose by 13% to $2.0 billion, as the growth acceleration was driven by the purchase of Faro. Electronic Instruments sales rose by nearly 6% to $4.92 billion, with Electromechanical sales up nearly 9% to $2.48 billion. The company grew operating margins by similar percentages, with net earnings up just over 7% to $1.48 billion. Such earnings growth and minimal share buybacks made GAAP earnings rise some forty-seven cents to $6.42 per share. Adjusted earnings rose by sixty cents to $7.43 per share, with the majority of the reconciliation driven by amortization charges, as these numbers look quite fair. Net debt is reported at $1.82 billion, trailing adju...